Benefits of SGLT2 inhibitors combining with renin–angiotensin-system blockers on cardiovascular outcomes in chronic kidney disease patients: A systemic review and meta-analysis

Autor: Liu, Ting, Li, Rui, Wang, Xiaoxia, Gao, Xingxing, Zhang, Xiaodong
Zdroj: In Medicina Clínica (English Edition) 22 July 2022 159(2):65-72
Databáze: ScienceDirect